BiochemistrybioRxivPreprint
Targeted Enzymatic Fragmentation of Lipoprotein(a) via Kringle IV Domains: A Novel Therapeutic Approach for Cardiovascular Disease.
This paper proposes an antibody-drug conjugate targeting KIV domains of Lp(a) to enhance its clearance via enzymatic fragmentation, showing potential for improved therapeutic outcomes in cardiovascular disease.
DOI 10.1101/2025.09.28.679088